Empowering Patient Voices in HEOR: The Critical Role of Patient-Generated Data and Preferences in Europe’s Evolving HTA Landscape
Patient-Generated Data and Preferences in Europe's evolving HTA landscape.
top of page
Evidence Generation Experts
We are experts in evidence generation specialising in real world evidence (RWE), preference research, and health economics and outcomes research (HEOR). Our in house team deliver industry standard qualitative, quantitative and mixed methods research, with peace of mind delivered through our integrated digital health, ethics, and data governance support.
What we do
Preference Research
We use preference exploration and elicitation techniques to understand patient preference and experience.
This evidence supports internal strategy, clinical development, product design, evidence generation plans, HTA assessments, reimbursement strategies and a products value proposition.
Real World Outcomes Research
We conduct real world evidence studies to quantify healthcare resource use, economics burden, clinical outcomes, health-related quality of life and patient and caregiver experience.
Our team tailor these studies to be conducted retrospectively, cross-sectionally and longitudinally.
Digital Health Technology
We believe digital health technologies can have a positive impact of health systems, outcomes and research. However, to achieve this we believe an approach to adoption must be evidence-based.
We place digital health technologies in research methodologies. We generate evidence for digital health solutions ensuring they meet their health economics and real world evidence requirements. Demonstrating the value of their product.
Ethics and Data Governance
We have in-house ethical, compliance and data governance expertise across geographical markets providing peace of mind and reassurance when conducting research.
We are open and transparent regarding our processes for gathering, storing, processing, and disposing of data. Developing data management plans for our research.
And more
We have a broad skill set with capabilities to support any evidence synthesis, statistical analysis and health economic modelling needs that you may require.
We offer comprehensive support for any evidence dissemination requirements including strategy planning, management and publication creation.
Who our work supports
Understand further how our services can benefit you and your organisation.
We support Pharmaceutical, Biotechnology and Medical Device companies. Specialising in rare disease.
We support Digital Health and Digital Therapeutic Companies.
Patient Organisations
We support Patient Advocacy Groups and other patient organisations.
Anchor 1
Our Leadership Team
Leveraging combined expertise.
DHT.health is led by Sam Bristow and George Morgan. Having worked together in previous companies focusing on Health Economics and Outcomes Research (HEOR), Real-World Evidence (RWE) and Digital Health. They combine their expertise to provide a comprehensive service focusing on industry standard RWE, HEOR, preference research delivered with integrated digital, ethics, compliance and data governance support.
Their mission is to identify and support unmet healthcare research needs by bringing together key stakeholders.
Don't take our word for it
Sam Bristow has for a number of years been a strategic advisor to the Haemophilia Society, a UK charity that supports people with genetic bleeding disorders. His expertise in evidence based decision making has helped us demonstrate our impact, secure funding and give people with bleeding disorders greater understanding of an access to the best treatment options available.
Kate Burt, CEO of The Haemophilia Society
bottom of page